Home » Newsletters » BioWorld Science

BioWorld Science

June 15, 1999

View Archived Issues

Final analysis of Lyon Diet Heart Study reported

Modified beta-lactoglobulin decreases vaginal transmission of SIV

ChemRx and DuPont sign chemistry collaboration

Follow-up data presented for Bexxar cancer therapy

Mechanism underlying Oxigene's tumor vascular targeting agent revealed

FDA approves initiation of clinical trial of strep vaccine

Cytogen updates Canadian product rights

Campath-1H trial results presented in Barcelona

Lamictal approved in Canada for Lennox-Gastaut syndrome

Ares-Serono will acquire marketing rights to Crinone

Phase I results on adenoviral-p53 therapy in non-small cell lung cancer

Fujisawa describes preparation and use of adenosine receptor antagonists

New PTK inhibitors developed at Bristol-Myers Squibb

Antiallergic phenothiazines patented by Eisai investigators

Substantially pure (S)-(+)-enantiomer form of ETA antagonist prepared at Pfizer

Warner-Lambert describes agents interacting with Ca2+ binding sites

Proteasome inhibitor CVT-634 prevents ischemic neuronal injury in rat model

Chemokine peptides designed at NeoRx useful for inflammatory disorders

Free radical-scavenging compound SPBN: therapeutic efficacy and potential complications

Antiinflammatory and immunosuppressive compounds related to leflunomide

Nisshin Flour Milling studies agents for diabetic complications

Abbott and Cephalon sign collaborative agreement for Gabitril

Trovan use also limited in Canada

Dendritic cell therapy: a novel treatment strategy for breast and ovarian cancers

Intranasal civamide evaluated for acute treatment of migraine

Treatment with MMP inhibitor attenuates ischemic damage in infarcted mice

Prophylaxis of migraine with oral dotarizine

Bisoprolol receives first European approval for chronic heart failure

Histamine desensitization in the Rx of chronic cluster headache

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...